{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:16Z","timestamp":1792788496381,"version":"4.5.0"},"reference-count":184,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020951","name":"Fonds de recherche du Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.anai.2026.05.027","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:48:31Z","timestamp":1779925711000},"page":"300-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["After the escalator"],"prefix":"10.1016","volume":"137","author":[{"given":"Morgane","family":"Gronnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-6886","authenticated-orcid":false,"given":"Simon","family":"Couillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2026.05.027_bib0001","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2458-12-204","article-title":"Global asthma prevalence in adults: findings from the cross-sectional world health survey","volume":"12","author":"To","year":"2012","journal-title":"BMC Public Health"},{"issue":"10440","key":"10.1016\/j.anai.2026.05.027_bib0002","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Ferrari","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.anai.2026.05.027_bib0003","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.5588\/ijtld.14.0170","article-title":"Global burden of asthma among children","volume":"18","author":"Asher","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.anai.2026.05.027_bib0004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.rmed.2018.03.018","article-title":"The projected economic and health burden of sub-optimal asthma control in Canada","volume":"138","author":"Zafari","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2026.05.027_bib0005","unstructured":"Global Initiative for Asthma \u2013 GINA. GINA strategy report. Accessed July 14, 2025. Available at: https:\/\/ginasthma.org\/2025-gina-strategy-report\/"},{"issue":"10379","key":"10.1016\/j.anai.2026.05.027_bib0006","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"issue":"10118","key":"10.1016\/j.anai.2026.05.027_bib0007","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"issue":"7059","key":"10.1016\/j.anai.2026.05.027_bib0008","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(58)91385-0","article-title":"Treatment of chronic asthma with prednisolone significance of eosinophils in the sputum","volume":"272","author":"Morrow Brown","year":"1958","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0009","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.anai.2022.02.005","article-title":"Should we apply a treatable traits approach to asthma care?","volume":"128","author":"Melhorn","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1164\/rccm.202412-2431VP","article-title":"Stop the asthma treatment elevator, we need to get off!","volume":"211","author":"Bush","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2026.05.027_bib0011","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention NHLBI\/WHO workshop report. Accessed July 15, 2025. Available at: https:\/\/ginasthma.org\/wp-content\/uploads\/2019\/01\/1995-GINA.pdf"},{"issue":"20","key":"10.1016\/j.anai.2026.05.027_bib0012","doi-asserted-by":"crossref","first-page":"E549","DOI":"10.1503\/cmaj.241770","article-title":"Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care","volume":"197","author":"Goupil","year":"2025","journal-title":"CMAJ Can Med Assoc J"},{"issue":"39","key":"10.1016\/j.anai.2026.05.027_bib0013","doi-asserted-by":"crossref","first-page":"E1333","DOI":"10.1503\/cmaj.221647","article-title":"Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update","volume":"195","author":"Morin","year":"2023","journal-title":"CMAJ Can Med Assoc J"},{"key":"10.1016\/j.anai.2026.05.027_bib0014","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe [the SCORE project]","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.anai.2026.05.027_bib0015","unstructured":"Diabetes Canada. Clinical practice guidelines. Accessed July 22, 2025. Available at: https:\/\/guidelines.diabetes.ca\/cpg"},{"issue":"10","key":"10.1016\/j.anai.2026.05.027_bib0016","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/2012.jama.10893","article-title":"Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the basalt randomized controlled trial","volume":"308","author":"Calhoun","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.anai.2026.05.027_bib0017","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1016\/j.jaip.2021.03.056","article-title":"Physician-patient concordance in the assessment of asthma control","volume":"9","author":"Fuhlbrigge","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2026.05.027_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2019.105859","article-title":"One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting \u03b22-agonist in UK primary care settings","volume":"162","author":"Buhl","year":"2020","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0019","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaip.2025.10.005","article-title":"Association of stepping up to high-dose inhaled corticosteroids and risk of future asthma exacerbations: data from the United States","volume":"14","author":"Tran","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2026.05.027_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(26)00150-5","article-title":"Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level analysis of randomised trials and translational prospective studies","author":"Couillard","year":"2026","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.anai.2026.05.027_bib0021","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1164\/rccm.201910-1934CI","article-title":"Optimal asthma control: time for a new target","volume":"201","author":"Beasley","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0022","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2026.05.027_bib0023","unstructured":"British Thoracic Society. Asthma: diagnosis, monitoring and chronic asthma management (BTS, Nice, SIGN). Accessed November 28, 2024. Available at: https:\/\/www.nice.org.uk\/guidance\/ng245\/resources\/asthma-diagnosis-monitoring-and-chronic-asthma-management-bts-nice-sign-pdf-66143958279109"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0024","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00570-2021","article-title":"Predicting the benefits of type 2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (Oracle)","volume":"8","author":"Couillard","year":"2021","journal-title":"ERJ Open Res"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.anai.2026.05.027_bib0026","first-page":"OA3761","article-title":"Multivariable prognostic relations of asthma attack risk factors in the Oracle patient-level meta-analysis","volume":"64","author":"Meulmeester","year":"2024","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058215","article-title":"Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling","volume":"12","author":"Couillard","year":"2022","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0028","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaip.2023.01.008","article-title":"Toward a predict and prevent approach in obstructive airway diseases","volume":"11","author":"Couillard","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2026.05.027_bib0029","doi-asserted-by":"crossref","unstructured":"Riemann S, Meulmeester FL, Mailhot-Larouche S, Ramakrishnan S, Wechsler ME, Corren J, et al. Sex does not modify prediction of asthma attacks by clinical risk factors and Type 2 biomarkers [e-pub ahead of print]. Chest. doi:10.1016\/j.chest.2025.12.049, accessed February 24, 2026.","DOI":"10.1016\/j.chest.2025.12.049"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(25)00037-2","article-title":"Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials","volume":"13","author":"Meulmeester","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202109-2205PP","article-title":"Global initiative for asthma strategy 2021 executive summary and rationale for key changes","volume":"205","author":"Reddel","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.anai.2026.05.027_bib0032","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201903-0599LE","article-title":"Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide, and their combination in severe asthma: a post hoc analysis","volume":"200","author":"Shrimanker","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.anai.2026.05.027_bib0033","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(20)30053-9","article-title":"Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial","volume":"8","author":"Pavord","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0034","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.anai.2026.05.027_bib0035","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S2213-2600(21)00124-7","article-title":"Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the Liberty ASTHMA QUEST study: a post-hoc analysis","volume":"9","author":"Busse","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0036","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00413-2021","article-title":"Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma","volume":"58","author":"Kraft","year":"2021","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0037","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.chest.2025.05.041","article-title":"In the land of asthma, four risk factors to rule them all","volume":"168","author":"Couillard","year":"2025","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0038","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.chest.2025.04.046","article-title":"Prediction pathway for severe asthma exacerbations: a Bayesian Network analysis","volume":"168","author":"Yadav","year":"2025","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0039","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1164\/rccm.201808-1516OC","article-title":"Exacerbation patterns in adults with Asthma in England: a population-based study","volume":"199","author":"Bloom","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-017-0409-3","article-title":"The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA","volume":"17","author":"Suruki","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"12","key":"10.1016\/j.anai.2026.05.027_bib0041","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1164\/rccm.202503-0721RL","article-title":"Normal FEV1 without reversibility in asthma trials - a placebo patient-level meta-analysis","volume":"211","author":"Couillard","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0042","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.anai.2024.09.023","article-title":"Identifying super-responders: a review of the road to asthma remission","volume":"134","author":"Mailhot-Larouche","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0043","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02536-2017","article-title":"Associations between blood eosinophils and decline in lung function among adults with and without asthma","volume":"51","author":"Hancox","year":"2018","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0044","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01785-2017","article-title":"Predictors of accelerated decline in lung function in adult-onset asthma","volume":"51","author":"Coumou","year":"2018","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.anai.2026.05.027_bib0045","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1164\/rccm.202310-1751LE","article-title":"Biomarkers associated with lung function decline and Dupilumab response in patients with asthma","volume":"209","author":"Pavord","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0046","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03823-2020","article-title":"Blood eosinophil counts and the development of obstructive lung disease: the Kangbuk Samsung Health Study","volume":"58","author":"Park","year":"2021","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0047","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/thorax-2023-220972","article-title":"Type 2 inflammation and lung function decline in chronic airway disease in the general population","volume":"79","author":"\u00c7olak","year":"2024","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0048","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.202104-1040LE","article-title":"Fractional exhaled nitric oxide nonsuppression identifies corticosteroid-resistant Type 2 signaling in severe asthma","volume":"204","author":"Couillard","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2026.05.027_bib0049","unstructured":"Couillard Castonguay S. Fractional exhaled nitric oxide non-suppression in asthma. University of Oxford, Master's thesis. Accessed July 15, 2025. Available at: https:\/\/ora.ox.ac.uk\/objects\/uuid:3312c52e-e5a0-4a5d-ac6d-15df48d44f5c"},{"key":"10.1016\/j.anai.2026.05.027_bib0050","first-page":"1","article-title":"Basic aspects of exhaled nitric oxide","author":"Alving","year":"2025","journal-title":"Exhaled Biomarkers"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0051","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0052","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01874-2019","article-title":"Blood eosinophil count in the general population: typical values and potential confounders","volume":"55","author":"Hartl","year":"2020","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0053","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4103\/ijmr.IJMR_1478_16","article-title":"Re-evaluation of the diagnostic value of fractional exhaled nitric oxide & its impact in patients with asthma","volume":"148","author":"He","year":"2018","journal-title":"Indian J Med Res"},{"issue":"7","key":"10.1016\/j.anai.2026.05.027_bib0054","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1080\/02770903.2017.1366509","article-title":"Validity of fractional exhaled nitric oxide and small airway function indices in diagnosis of cough-variant asthma","volume":"55","author":"Feng-jia","year":"2018","journal-title":"J Asthma"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0055","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/02770903.2016.1238926","article-title":"Comparison of diagnostic validity of mannitol and methacholine challenges and relationship to clinical status and airway inflammation in steroid-na\u00efve asthmatic patients","volume":"54","author":"Porpodis","year":"2017","journal-title":"J Asthma"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0056","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.anai.2016.07.032","article-title":"Evaluation of exhaled nitric oxide\u2019s ability to predict methacholine challenge in adults with nonobstructive spirometry","volume":"117","author":"Nickels","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0057","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.chest.2021.07.008","article-title":"Workup of severe asthma","volume":"160","author":"Couillard","year":"2021","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0058","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2016.19627","article-title":"Reevaluation of diagnosis in adults with physician-diagnosed asthma","volume":"317","author":"Aaron","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.anai.2026.05.027_bib0059","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1164\/rccm.201804-0682CI","article-title":"Underdiagnosis and overdiagnosis of asthma","volume":"198","author":"Aaron","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ppul.23541","article-title":"Misdiagnosis of asthma in schoolchildren","volume":"52","author":"Yang","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"644","key":"10.1016\/j.anai.2026.05.027_bib0061","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.3399\/bjgp16X683965","article-title":"Overdiagnosis of asthma in children in primary care: a retrospective analysis","volume":"66","author":"Looijmans-Van Den Akker","year":"2016","journal-title":"Br J Gen Pract"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0062","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01585-2021","article-title":"European Respiratory Society guidelines for the diagnosis of asthma in adults","volume":"60","author":"Louis","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2026.05.027_bib0063","unstructured":"Global Initiative for Asthma \u2013 GINA. GINA main report. Accessed July 14, 2025. Available at: https:\/\/ginasthma.org\/2024-report\/"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0064","first-page":"348","article-title":"Canadian Thoracic Society 2021 guideline update: diagnosis and management of asthma in preschoolers, children and adults","volume":"5","author":"Yang","year":"2021","journal-title":"Can J Respir Crit Care Sleep Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.chest.2020.03.052","article-title":"Performance characteristics of spirometry with negative bronchodilator response and methacholine challenge testing and implications for asthma diagnosis","volume":"158","author":"Selvanathan","year":"2020","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0066","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1164\/rccm.202308-1436OC","article-title":"Prevalence, diagnostic utility and associated characteristics of bronchodilator responsiveness","volume":"209","author":"Beasley","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0067","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01526-2016","article-title":"ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests","volume":"49","author":"Coates","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2026.05.027_bib0068","unstructured":"Universit\u00e9 de Sherbrooke. Internal Data Collated."},{"key":"10.1016\/j.anai.2026.05.027_bib0069","doi-asserted-by":"crossref","DOI":"10.1177\/17534666231181259","article-title":"A comparative study on the value of lower airway exhaled nitric oxide combined with small airway parameters for diagnosing cough-variant asthma","volume":"17","author":"Bai","year":"2023","journal-title":"Ther Adv Respir Dis"},{"issue":"9","key":"10.1016\/j.anai.2026.05.027_bib0070","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3390\/jcm12093330","article-title":"Value of fractional exhaled nitric oxide in diagnosing mild asthma responsive to inhaled corticosteroids","volume":"12","author":"Karamarkovic Lazarusic","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0071","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12007","article-title":"The value of small airway function parameters and fractional exhaled nitric oxide for predicting positive methacholine challenge test in asthmatics of different ages with FEV1 \u2265 80% predicted","volume":"11","author":"Hou","year":"2021","journal-title":"Clin Transl Allergy"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0072","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/02770903.2019.1694035","article-title":"Diagnostic value of FeNO and MMEF for predicting cough variant asthma in chronic cough patients with or without allergic rhinitis","volume":"58","author":"Chen","year":"2021","journal-title":"J Asthma"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0073","first-page":"150","article-title":"Determination of a cut-off point for exhaled nitric oxide in the diagnosis of asthma in an Iranian population","volume":"20","author":"Fard","year":"2021","journal-title":"Tanaffos"},{"issue":"7","key":"10.1016\/j.anai.2026.05.027_bib0074","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1080\/02770903.2021.1923741","article-title":"Blood eosinophils, FeNO and small airways dysfunction in predicting airway hyperresponsiveness in patients with asthma-like symptoms","volume":"59","author":"Urbankowski","year":"2022","journal-title":"J Asthma"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0075","doi-asserted-by":"crossref","first-page":"00169","DOI":"10.1183\/23120541.00169-2020","article-title":"Are type 2 biomarkers of any help in asthma diagnosis?","volume":"6","author":"Nekoee","year":"2020","journal-title":"ERJ Open Res"},{"issue":"1128","key":"10.1016\/j.anai.2026.05.027_bib0076","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/postgradmedj-2018-136333","article-title":"Clinical utility of ultrahigh fractional exhaled nitric oxide in predicting bronchial hyperresponsiveness in patients with suspected asthma","volume":"95","author":"Liu","year":"2019","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0077","first-page":"5570","article-title":"Diagnostic value and influencing factors of fractional exhaled nitric oxide in suspected asthma patients","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"10.1016\/j.anai.2026.05.027_bib0078","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/cea.12427","article-title":"Can we predict allergen-induced asthma in patients with allergic rhinitis?","volume":"44","author":"Buslau","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0079","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000341675","article-title":"Exhaled nitric oxide may predict bronchial hyperreactivity in patients with allergic rhinitis","volume":"160","author":"Cirillo","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000350221","article-title":"Exhaled nitric oxide as screening tool in subjects with suspected asthma without reversibility","volume":"162","author":"Katsoulis","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0081","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/crj.12014","article-title":"Exhaled nitric oxide indicates poorly athlete\u2019s asthma","volume":"7","author":"Voutilainen","year":"2013","journal-title":"Clin Respir J"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0082","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1742-1241.2011.02840.x","article-title":"Is FE NO50 useful diagnostic tool in suspected asthma?","volume":"66","author":"Schleich","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0083","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2332\/allergolint.10-OA-0277","article-title":"Exhaled nitric oxide cutoff values for asthma diagnosis according to rhinitis and smoking status in Japanese subjects","volume":"60","author":"Matsunaga","year":"2011","journal-title":"Allergol Int"},{"issue":"11","key":"10.1016\/j.anai.2026.05.027_bib0084","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.rmed.2011.06.001","article-title":"Predicted versus absolute values in the application of exhaled nitric oxide measurements","volume":"105","author":"Leon De La Barra","year":"2011","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0085","doi-asserted-by":"crossref","first-page":"AB7","DOI":"10.1016\/j.jaci.2009.12.057","article-title":"Usefulness of exhaled nitric oxide in asthma diagnosis","volume":"125","author":"Pedrosa","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2026.05.027_bib0086","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/02770900903056187","article-title":"Exhaled nitric oxide in evaluation of young adults with chronic cough","volume":"46","author":"Kowal","year":"2009","journal-title":"J Asthma"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0087","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1465-9921-10-15","article-title":"Diagnosing Asthma in General Practice with Portable Exhaled nitric oxide Measurement - Results of a Prospective Diagnostic Study: FENO \u2264 16 ppb better than FENO \u2264 12 ppb to rule out mild and moderate to severe asthma","volume":"10","author":"Schneider","year":"2009","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0088","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1378\/chest.06-2218","article-title":"Diagnostic tests for asthma in firefighters","volume":"131","author":"David","year":"2007","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.anai.2026.05.027_bib0089","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.rmed.2007.05.019","article-title":"Diagnostic utility of inflammatory biomarkers in asthma: exhaled nitric oxide and induced sputum eosinophil count","volume":"101","author":"Fortuna","year":"2007","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.anai.2026.05.027_bib0090","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.rmed.2006.02.019","article-title":"Exhaled nitric oxide as a diagnostic test for asthma in rhinitic patients with asthmatic symptoms","volume":"100","author":"Heffler","year":"2006","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0091","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1164\/rccm.200310-1376OC","article-title":"Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests","volume":"169","author":"Smith","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0092","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1378\/chest.123.3.751","article-title":"Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma","volume":"123","author":"Dupont","year":"2003","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0093","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1164\/ajrccm.159.6.9809047","article-title":"Exhaled nitric oxide as a noninvasive assessment of chronic cough","volume":"159","author":"Chatkin","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2026.05.027_bib0094","doi-asserted-by":"crossref","unstructured":"Roy MA, Gronnier M, Manisha Ramphul A, Divall P, Lemaire-Paquette S, C\u00f4t\u00e9 A, et al. Diagnostic accuracy of fractional exhaled nitric oxide (FeNO) with or without blood eosinophils in childhood, adolescent, and adult asthma: protocol for a systematic review and meta-analysis. medRxiv; 2024;2024.07.14.24310394. Accessed November 2, 2024. Available at https:\/\/www.medrxiv.org\/content\/10.1101\/2024.07.14.24310394v1.","DOI":"10.1101\/2024.07.14.24310394"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0096","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12890-021-01626-z","article-title":"Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma","volume":"21","author":"Li","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.anai.2026.05.027_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101533","article-title":"Diagnostic accuracy of FeNO in asthma and predictive value for inhaled corticosteroid responsiveness: a prospective, multicentre study","volume":"50","author":"Schneider","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"8","key":"10.1016\/j.anai.2026.05.027_bib0097","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cea.14374","article-title":"Exhaled nitric oxide (FeNO): bridging a knowledge gap in asthma diagnosis and treatment","volume":"53","author":"Celis-Preciado","year":"2023","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0099","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01832-2024","article-title":"Viewpoint: a white paper for a greener design, conduct and reporting of clinical trials in respiratory medicine","volume":"65","author":"Couillard","year":"2025","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0100","doi-asserted-by":"crossref","first-page":"00577","DOI":"10.1183\/23120541.00577-2024","article-title":"The carbon footprint of diagnostic delays in asthma","volume":"11","author":"Pouliot","year":"2025","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0101","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaip.2023.10.053","article-title":"Further fine-tuning of the interpretation of FeNO measurement in asthma","volume":"12","author":"Alving","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0102","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1203\/01.PDR.0000081761.33822.36","article-title":"Nitric oxide airway diffusing capacity and mucosal concentration in asthmatic schoolchildren","volume":"54","author":"Pedroletti","year":"2003","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0103","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/cs0450375","article-title":"Prediction of the physiological dead space in resting normal subjects","volume":"45","author":"Harris","year":"1973","journal-title":"Clin Sci"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0104","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaci.2025.12.1010","article-title":"Sex-based hormonal influences on asthma biomarkers","volume":"157","author":"Jagadish","year":"2026","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0105","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04173-2020","article-title":"European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years","volume":"58","author":"Gaillard","year":"2021","journal-title":"Eur Respir J"},{"issue":"7458","key":"10.1016\/j.anai.2026.05.027_bib0106","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/bmj.329.7458.168","article-title":"Statistics notes: diagnostic tests 4: Likelihood ratios","volume":"329","author":"Deeks","year":"2004","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0107","doi-asserted-by":"crossref","first-page":"00309","DOI":"10.1183\/23120541.00309-2020","article-title":"Identification and treatment of T2-low asthma in the era of biologics","volume":"7","author":"Kyriakopoulos","year":"2021","journal-title":"ERJ Open Res"},{"issue":"21","key":"10.1016\/j.anai.2026.05.027_bib0108","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.3390\/cells12212518","article-title":"Exhaled nitric oxide as biomarker of Type 2 diseases","volume":"12","author":"Maniscalco","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0109","first-page":"3750","article-title":"Integrating blood eosinophils and exhaled nitric oxide (FeNO) in asthma diagnostic pathways for adults and children: the PROPULSION SANT\u00c9 observational study with translational sub-studies (DIVE, DIVE2)\u2014protocols","volume":"12","author":"Gronnier","year":"2025","journal-title":"BMJ Open Respir Res"},{"issue":"21","key":"10.1016\/j.anai.2026.05.027_bib0110","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.anai.2026.05.027_bib0111","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","article-title":"Inhaled combined budesonide\u2013formoterol as needed in mild asthma","volume":"378","author":"O\u2019Byrne","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.anai.2026.05.027_bib0112","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1715275","article-title":"As-Needed budesonide\u2013formoterol versus Maintenance budesonide in Mild Asthma","volume":"378","author":"Bateman","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0113","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa2504544","article-title":"As-needed albuterol\u2013budesonide in mild asthma","volume":"393","author":"LaForce","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0114","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/resp.14213","article-title":"Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma","volume":"27","author":"Couillard","year":"2022","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0115","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaip.2024.01.039","article-title":"Baseline characteristics and ICS\/LAMA\/LABA response in asthma: analyses from the CAPTAIN study","volume":"12","author":"Boulet","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2026.05.027_bib0116","first-page":"140","article-title":"Effect of inhaled formoterol and budesonide on exacerbations of asthma","volume":"52","author":"Pauwels","year":"1998","journal-title":"Pneumologie"},{"issue":"12","key":"10.1016\/j.anai.2026.05.027_bib0117","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1164\/rccm.201810-1868CI","article-title":"Inhaled corticosteroid therapy in adult asthma time for a new therapeutic dose terminology","volume":"199","author":"Beasley","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0118","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.chest.2025.08.014","article-title":"The dose-response of inhaled corticosteroids in combination inhaled corticosteroid\/long acting Beta2-agonist maintenance therapy for asthma: a systematic review and meta-analysis","volume":"168","author":"Noble","year":"2025","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.anai.2026.05.027_bib0119","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jaip.2025.01.023","article-title":"Use of high-dose inhaled corticosteroids and risk of corticosteroid-related adverse events in asthma findings from the NORDSTAR cohort","volume":"13","author":"von B\u00fclow","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0120","first-page":"756","article-title":"Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review","volume":"7","author":"Patel","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0121","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202402-0368OC","article-title":"Association of dose of inhaled corticosteroids and frequency of adverse events","volume":"211","author":"Bloom","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.anai.2026.05.027_bib0122","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The gaining optimal asthma control study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0123","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jaip.2022.10.040","article-title":"Effect of stepping up to high-dose inhaled corticosteroids in patients with Asthma: UK database study","volume":"11","author":"Pavord","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.anai.2026.05.027_bib0124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003145","article-title":"Health and cost impact of stepping down asthma medication for UK patients, 2001-2017: a population-based observational study","volume":"17","author":"Bloom","year":"2020","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.anai.2026.05.027_bib0125","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjmed.2010.06.019","article-title":"Inhaled corticosteroids and the risks of diabetes onset and progression","volume":"123","author":"Suissa","year":"2010","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.anai.2026.05.027_bib0126","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1440-1843.2009.01589.x","article-title":"Dose-response relationship of inhaled corticosteroids and cataracts: a systematic review and meta-analysis","volume":"14","author":"Weatherall","year":"2009","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0127","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1183\/09031936.06.00119305","article-title":"Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis","volume":"28","author":"Masoli","year":"2006","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.anai.2026.05.027_bib0128","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1365-2222.2008.03029.x","article-title":"Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids","volume":"38","author":"Weatherall","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2026.05.027_bib0129","unstructured":"Global Initiative for COPD (GOLD). Global strategy for prevention, diagnosis and management of COPD. Accessed March 14, 2026. Available at: https:\/\/goldcopd.org\/2021-gold-reports\/"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type 2 biomarker strategy versus a symptom\u2013risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/thoraxjnl-2015-207326","article-title":"Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)","volume":"71","author":"Heaney","year":"2015","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.anai.2026.05.027_bib0132","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jaip.2025.04.055","article-title":"Diagnosis and treatment options for T2-low asthma","volume":"13","author":"Thomas","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0133","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2026.05.027_bib0134","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/thoraxjnl-2021-217994","article-title":"Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.201806-1182OC","article-title":"Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma","volume":"199","author":"Heaney","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0136","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chest.2016.03.041","article-title":"Systematic review of errors in inhaler use: has patient technique improved over time?","volume":"150","author":"Sanchis","year":"2016","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0137","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4140\/TCP.n.2015.92","article-title":"Inhaler misuse in an older adult population","volume":"30","author":"Vanderman","year":"2015","journal-title":"Consult Pharm"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0138","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1710-1492-9-8","article-title":"Improper inhaler technique is associated with poor asthma control and frequent emergency department visits","volume":"9","author":"Al-Jahdali","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0139","doi-asserted-by":"crossref","first-page":"00273","DOI":"10.1183\/23120541.00273-2021","article-title":"Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy","volume":"7","author":"Butler","year":"2021","journal-title":"ERJ Open Res"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.chest.2024.08.045","article-title":"Choosing the right biologic for the right patient with severe asthma","volume":"167","author":"Couillard","year":"2025","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.anai.2026.05.027_bib0141","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1164\/rccm.202003-0729LE","article-title":"Blood eosinophil depletion with mepolizumab, Benralizumab, and prednisolone in eosinophilic asthma","volume":"202","author":"Moran","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"10.1016\/j.anai.2026.05.027_bib0142","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM195110112451501","article-title":"Clinical studies on the activity of orally administered cortisone","volume":"245","author":"Thorn","year":"1951","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0143","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0091-6749(93)90270-P","article-title":"Effect of inhaled corticosteroids on peripheral blood eosinophil counts and density profiles in asthma","volume":"91","author":"Evans","year":"1993","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0144","article-title":"Corticosteroids for preventing relapse following acute exacerbations of asthma","volume":"2007","author":"Rowe","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0145","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00183-2021","article-title":"Antibiotics for asthma attacks: masking uncertainty","volume":"58","author":"Ramakrishnan","year":"2021","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0146","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0002-9343(83)90871-9","article-title":"Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma","volume":"75","author":"Baigelman","year":"1983","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0147","first-page":"251","article-title":"Inverse correlation of expiratory lung flows and sputum eosinophils in status asthmaticus","volume":"63","author":"Alfaro","year":"1989","journal-title":"Ann Allergy"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0148","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0091-6749(95)70128-1","article-title":"Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation","volume":"95","author":"Fahya","year":"1995","journal-title":"J Allergy Clin Immunol"},{"issue":"4 Pt 1","key":"10.1016\/j.anai.2026.05.027_bib0149","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1164\/ajrccm.161.4.9812061","article-title":"Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma clinical and biologic significance","volume":"161","author":"Ordo\u00f1ez","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0150","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jaci.2018.04.013","article-title":"Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles","volume":"141","author":"Ghebre","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2026.05.027_bib0151","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1111\/all.15425","article-title":"Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation","volume":"77","author":"Diver","year":"2022","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0152","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1164\/ajrccm.155.5.9154849","article-title":"Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment","volume":"155","author":"Pizzichini","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.anai.2026.05.027_bib0153","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S2213-2600(21)00004-7","article-title":"The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study","volume":"9","author":"McDowell","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0154","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1164\/rccm.202201-0129OC","article-title":"Exacerbation profile and risk factors in a type 2-low enriched severe asthma cohort A clinical trial to assess asthma exacerbation phenotypes","volume":"206","author":"McDowell","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0155","article-title":"Paradoxical eosinophilic and cytokine responses to oral corticosteroid treatment in patients with asthma exacerbations","volume":"3","author":"Maneechotesuwan","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0156","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02391-2024","article-title":"Phenotyping the responses to systemic corticosteroids in the management of asthma attacks (PRISMA)","volume":"65","author":"Celis-Preciado","year":"2025","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0157","article-title":"Phenotyping the Responses to Systemic corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study","volume":"10","author":"Celis-Preciado","year":"2023","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0158","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-2600(24)00299-6","article-title":"Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial","volume":"13","author":"Ramakrishnan","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0159","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.anai.2026.05.027_bib0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/resp.14294","article-title":"Sub-stratification of type 2 high airway disease for therapeutic decision-making: a \u2018bomb\u2019 (blood eosinophils) meets \u2018magnet\u2019 (FeNO) framework","volume":"27","author":"Couillard","year":"2022","journal-title":"Respirology"},{"issue":"26","key":"10.1016\/j.anai.2026.05.027_bib0161","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.anai.2026.05.027_bib0162","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0163","doi-asserted-by":"crossref","DOI":"10.1016\/j.reval.2023.103596","article-title":"Efficacit\u00e9 du t\u00e9z\u00e9p\u00e9lumab chez les patients asthmatiques s\u00e9v\u00e8res non contr\u00f4l\u00e9s avec des comorbidit\u00e9s respiratoires : r\u00e9sultats de l\u2019\u00e9tude de Phase 3 NAVIGATOR","volume":"63","author":"Carr","year":"2023","journal-title":"Rev Fr Allergol"},{"key":"10.1016\/j.anai.2026.05.027_bib0164","doi-asserted-by":"crossref","unstructured":"Corren J, Menzies-Gow A, Chupp G, Israel E, Korn S, Cook B, et al. Efficacy of tezepelumab in severe, uncontrolled asthma: pooled analysis of the PATHWAY and NAVIGATOR clinical trials. 2023;208(1):13-24.","DOI":"10.1164\/rccm.202210-2005OC"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0165","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jaip.2025.01.017","article-title":"Poor agreement among asthma specialists on the choice and timing of initiation of a biologic treatment for severe asthma patients","volume":"13","author":"C\u00f4t\u00e9","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10423","key":"10.1016\/j.anai.2026.05.027_bib0166","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","article-title":"Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study","volume":"403","author":"Jackson","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-7022-3-37","article-title":"Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care","volume":"3","author":"Price","year":"2013","journal-title":"Clin Transl Allergy"},{"issue":"6","key":"10.1016\/j.anai.2026.05.027_bib0168","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jaip.2022.02.014","article-title":"Benralizumab effectiveness in severe asthma is independent of previous biologic use","volume":"10","author":"Jackson","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0169","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jaci.2024.07.020","article-title":"Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma","volume":"154","author":"Howell","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0170","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01229-2025","article-title":"Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5\/5R\u03b1 therapy: a prospective observational study","volume":"66","author":"Howell","year":"2025","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.anai.2026.05.027_bib0171","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00396-2021","article-title":"Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)","volume":"59","author":"Moore","year":"2022","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.anai.2026.05.027_bib0172","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S2213-2600(22)00492-1","article-title":"Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study","volume":"11","author":"Menzies-Gow","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.anai.2026.05.027_bib0173","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S2213-2600(24)00383-7","article-title":"Asthma: epidemiology, risk factors, and opportunities for prevention and treatment","volume":"13","author":"Jayasooriya","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0174","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S2214-109X(22)00506-X","article-title":"Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study","volume":"11","author":"Garc\u00eda-Marcos","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.18176\/jiaci.0103","article-title":"Cost-effectiveness and budget impact of routine use of fractional exhaled nitric oxide monitoring for the management of adult asthma patients in Spain","volume":"27","author":"Sabatelli","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0176","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1398-9995.2008.01855.x","article-title":"An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom","volume":"64","author":"Price","year":"2009","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2026.05.027_bib0177","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00194-2020","article-title":"Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma","volume":"56","author":"Taylor","year":"2020","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0178","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201809-1739OC","article-title":"Long-term azithromycin reduces Haemophilus influenzae and increases antibiotic resistance in severe asthma","volume":"200","author":"Taylor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"10095","key":"10.1016\/j.anai.2026.05.027_bib0179","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.chest.2024.02.048","article-title":"Effect of azithromycin on asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomized, double-anonymized, placebo-controlled trial","volume":"166","author":"Thomas","year":"2024","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.anai.2026.05.027_bib0181","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1411532","article-title":"Lung-function trajectories leading to chronic obstructive pulmonary disease","volume":"373","author":"Lange","year":"2015","journal-title":"N Engl J Med"},{"issue":"6077","key":"10.1016\/j.anai.2026.05.027_bib0182","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/bmj.1.6077.1645","article-title":"The natural history of chronic airflow obstruction","volume":"1","author":"Fletcher","year":"1977","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.anai.2026.05.027_bib0183","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2213-2600(22)00364-2","article-title":"Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study","volume":"11","author":"Dharmage","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"13","key":"10.1016\/j.anai.2026.05.027_bib0184","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.anai.2026.05.027_bib0185","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.2018.2769","article-title":"Association of inhaled corticosteroids and long-acting \u03b2-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626002310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626002310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:05:03Z","timestamp":1788293103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626002310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":184,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1081120626002310"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.05.027","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"After the escalator","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}